Multiple Dialogues of MS

Welcome to BiogenTalks and Multiple Dialogues of MS. Podcasts are intended for Healthcare Professionals only. Please do not share or distribute. This podcast series contains interviews with some of the world-leading experts in Multiple Sclerosis. In each episode you will receive useful information and advice on important themes and relevant questions.

2021

The 2021 BiogenTalks episodes are hosted by Prof Robertson

Bio Professor Robertson

The 2021 episodes of BiogenTalks are hosted by Professor Derrick Robertson. Professor Robertson is Associate Professor of Neurology, Director of the Multiple Sclerosis Division, and Program Director of the Multiple Sclerosis Fellowship Program at the University of South Florida Morsani College of Medicine in Tampa, Florida, USA. His primary research interests include clinical trials assessing novel treatments for both relapsing–remitting and secondary-progressive multiple sclerosis as well as medical student and resident education. Professor Robertson is board-certified by the American Board of Psychiatry and Neurology. He is a member of the American Neurological Association, American Academy of Neurology, and Florida Society of Neurology.

Professor Carlo Tornatore and Dr. Wallace Brownlee:

MS treatment in the era of COVID-19 (part 3): the impact of COVID-19 and the vaccination roll-out on the management and treatment of patients with multiple sclerosis.

This episode uses a case study-based approach to explore the following topics: 

  • Whether our choice and use of disease-modifying therapies have changed since the start of the pandemic and the roll-out of vaccinations 
  • The benefits and risks of COVID-19 vaccination in people with multiple sclerosis 
  • What measures, if any, people with multiple sclerosis should take to protect themselves from COVID-19, besides vaccination.
Bio Professor Carlo Tornatore & Dr. Wallace Brownlee

Professor Carlo Tornatore serves as Professor and Chairman of the Department of Neurology at Georgetown University Medical Center in Washington D.C., USA. He is also Regional Chief of Neurology for MedStar Health, Chairman and Neurologist-in-Chief at MedStar Georgetown University Hospital, and Executive Director of the Multiple Sclerosis Patient-Centered Specialty Practice MedStar Georgetown. Professor Tornatore has published extensively in the areas of clinical and translational neuroimmunology and neurovirology, and is actively involved in over 15 MS clinical trials. 

Dr. Wallace Brownlee is a Consultant Neurologist and Clinical Lead for the Multiple Sclerosis Service at the National Hospital for Neurology and Neurosurgery, and Honorary Associate Professor at UCL Queen Square Institute of Neurology in London, UK. Dr. Brownlee is Principal Investigator for a number of ongoing phase 3 clinical trials in MS and neuromyelitis optica spectrum disorder, and Associate Editor of Multiple Sclerosis Journal, leading on case reports and social media.

Dr. Wallace Brownlee and Professor Carlo Tornatore:

MS treatment in the era of COVID-19 (part 4): what the future looks like for consultations and multiple sclerosis research.

This episode covers the following topics: 

  • Whether the COVID-19 pandemic has impacted on the diagnosis and care of people with multiple sclerosis, and any knock-on effects this may have had on disease course 
  • The advantages and disadvantages of teleneurology, and whether it is here to stay 
  • The impact of COVID-19 on research in multiple sclerosis, and how the future of multiple sclerosis research looks.
Bio Professor Carlo Tornatore & Dr. Wallace Brownlee

Dr. Wallace Brownlee is a Consultant Neurologist and Clinical Lead for the Multiple Sclerosis Service at the National Hospital for Neurology and Neurosurgery, and Honorary Associate Professor at UCL Queen Square Institute of Neurology in London, UK. Dr. Brownlee is Principal Investigator for a number of ongoing phase 3 clinical trials in MS and neuromyelitis optica spectrum disorder, and Associate Editor of Multiple Sclerosis Journal, leading on case reports and social media.

Professor Carlo Tornatore serves as Professor and Chairman of the Department of Neurology at Georgetown University Medical Center in Washington D.C., USA. He is also Regional Chief of Neurology for MedStar Health, Chairman and Neurologist-in-Chief at MedStar Georgetown University Hospital, and Executive Director of the Multiple Sclerosis Patient-Centered Specialty Practice MedStar Georgetown. Professor Tornatore has published extensively in the areas of clinical and translational neuroimmunology and neurovirology, and is actively involved in over 15 MS clinical trials. 

Dr. Barry Singer and Dr. Amy Lovett-Racke:

MS treatment in the era of COVID-19 (part 5): the immunology of COVID-19 vaccinations in people with multiple sclerosis.

This episode is an excerpt from a discussion at the 2021 American Academy of Neurology Annual Meeting covering the following topics: 

  • The immune response to traditional and mRNA vaccines, and the issue of variants 
  • Markers of immunity to COVID-19, the impact of age on vaccine efficacy, and generating long-term immunity.
Bio Dr. Barry Singer & Dr. Amy Lovett-Racke

Dr. Barry Singer is Director and Founder of The MS Center for Innovations in Care at Missouri Baptist Medical Center in St. Louis, Missouri, USA. He is an Associate Professor of Clinical Neurology at Washington University in St. Louis. Dr. Singer has been an investigator in over 35 MS clinical trials focused on new therapeutics. In 2016, he was appointed to the Board of Directors of the Multiple Sclerosis Association of America. His award-winning MS patient education website www.mslivingwell.org was created in 2007 and has been a valuable resource in more than 190 countries. 

Dr. Amy Lovett-Racke is a Professor in the Department of Microbial Infection and Immunity and a member of the Infectious Diseases Institute at The Ohio State University Wexner Medical Center in Columbus, Ohio, USA. She is also a Section Editor for The Journal of Immunology and serves as a committee member for the National Multiple Sclerosis Society’s Pathways to Cure MS. She has published extensively on the role of T cells and their interactions with other cells of the immune and central nervous systems in the onset and progression of MS.

2020

Professor Dr. Bart van Wijmeersch:

Walking impairment in Multiple Sclerosis (MS): Symptoms, evaluation, and the role of exercise.

Professor Dr. Bart van Wijmeersch:

Walking impairment in Multiple Sclerosis (MS): The latest research.

Professor Gabriel Pardo:

Sequencing therapies in Multiple Sclerosis: Opportunities and strategic thinking.

Professor Gabriel Pardo:

Sequencing therapies in Multiple Sclerosis: Managing patients throughout the disease journey.

Professor Carlo Tornatore and Dr. Wallace Brownlee:

MS treatment in the era of COVID-19 (part 1): Disease management, virtual consultations and the global data sharing initiative.

Professor Carlo Tornatore and Dr. Wallace Brownlee:

MS treatment in the era of COVID-19 (part 2): Immunology, vaccination readiness and the upcoming flu season.

Professor Thomas Berger:

Understanding the effects of MS treatment with patient-reported outcomes (PROs).

Professor Dr. Stefan Braune:

Personalized medicine in multiple sclerosis (MS).

Professor Dr. Tomas Kalincik and Professor Dr. Richard Nicholas:

Pearls and pitfalls of real-world evidence (RWE).

Professor Dr. Tomas Kalincik and Professor Dr. Richard Nicholas:

How can we improve real-world data collection in multiple sclerosis (MS)?

Dr. Orla Gray and Dr. Owen Pearson:

What does the future in RWE look like?

Nurse Practitioner Trudy Campbell:

Nursing strategies to improve MS patients´ adherence and persistence.

Professor Ralf Gold:

Key Learnings from up to 13 years of follow-up with TECFIDERA® (dimethyl fumarate) treatment experience.

Professor Ralf Gold:

Safety data from up to 13 years of long-term follow-up with TECFIDERA® (dimethyl fumarate) treatment.

Biogen-127959.
Date of preparation: August 2021.